This report describes and explains the clinical genomics sequencing, biobank, database services market and covers 2020-2025, termed the historic period, and 2025-2030, 2035F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global clinical genomics sequencing, biobank, database services market reached a value of nearly $8.1 billion in 2025, having grown at a compound annual growth rate (CAGR) of 15.6% since 2020. The market is expected to grow from $8.1 billion in 2025 to $15.88 billion in 2030 at a rate of 14.4%. The market is then expected to grow at a CAGR of 13.7% from 2030 and reach $30.18 billion in 2035.
Growth in the historic period resulted from rising prevalence of diseases with genetic components, growth in clinical trials and research activities, expansion of biobanks and sample repositories and rising prevalence of rare diseases. Factors that negatively affected growth in the historic period were ethical and public trust concerns and data integration and interoperability issues.
Going forward, rising adoption of precision and personalized medicine, growing pharma demand for genomic data in drug discovery, rising prevalence of chronic diseases and expansion of pharmacogenomics testing will drive growth. Factors that could hinder the growth of the clinical genomics sequencing, biobank, database services market in the future include high sequencing and biobanking costs, data privacy and regulatory barriers and impact of trade war and tariff.
The clinical genomics sequencing, biobank, database services market is segmented by funding type into government-sponsored and commercial services. The commercial services market was the largest segment of the clinical genomics sequencing, biobank, database services market segmented by funding type, accounting for 57.7% or $4.65 billion of the total in 2025. Going forward, the commercial services segment is expected to be the fastest growing segment in the clinical genomics sequencing, biobank, database services market segmented by funding type, at a CAGR of 18.1% during 2025-2030.
The clinical genomics sequencing, biobank, database services market is segmented by disease area into oncology, rare genetic disorders, infectious diseases, reproductive health and other disease areas. The oncology market was the largest segment of the clinical genomics sequencing, biobank, database services market segmented by disease area, accounting for 40.3% or $3.26 billion of the total in 2025. Going forward, the rare genetic disorders segment is expected to be the fastest-growing segment in the clinical genomics sequencing, biobank, database services market segmented by disease area, at a CAGR of 15.3% during 2025-2030.
The clinical genomics sequencing, biobank, database services market is segmented by end-user into hospitals and clinics, diagnostic laboratories, research institutes and universities, pharmaceutical and biotechnology companies, contract research organizations (CROs) and other end users. The pharmaceutical and biotechnology companies market was the largest segment of the clinical genomics sequencing, biobank, database services market segmented by end-user, accounting for 45.3% or $3.67 billion of the total in 2025. Going forward, the pharmaceutical and biotechnology companies segment is expected to be the fastest-growing segment in the clinical genomics sequencing, biobank, database services market segmented by end-user, at a CAGR of 16.4% during 2025-2030.
The clinical genomics sequencing, biobank, database services market is segmented by service type into clinical genomics sequencing, biobank services and database and bioinformatics services. The clinical genomics sequencing market was the largest segment of the clinical genomics sequencing, biobank, database services market segmented by service type, accounting for 49.4% or $4.0 billion of the total in 2025. Going forward, the database and bioinformatics services segment is expected to be the fastest growing segment in the clinical genomics sequencing, biobank, database services market segmented by service type, at a CAGR of 15.5% during 2025-2030.
The global clinical genomics sequencing, biobank, database services market is fairly concentrated, with large players operating in the market. The top 10 competitors in the market made up 25.30% of the total market in 2024. Illumina Inc was the largest competitor with a 3.30% share of the market, followed by Thermo Fisher Scientific Inc with 2.99%, BGI Genomics Co. Ltd with 2.78%, Eurofins Scientific SE with 2.72%, Quest Diagnostics Inc with 2.55%, Hamilton Company with 2.53%, Invitae Corp with 2.39%, Tempus AI Inc with 2.34%, Novogene Corporation with 1.96% and 23andMe Holding Inc with 1.74%.
The top opportunities in the clinical genomics sequencing, biobank, database services market segmented by funding type will arise in the commercial services segment, which will gain $6.05 billion of global annual sales by 2030. The top opportunities in the clinical genomics sequencing, biobank, database services market segmented by disease area will arise in the oncology segment, which will gain $3.17 billion of global annual sales by 2030. The top opportunities in the clinical genomics sequencing, biobank, database services market segmented by service type will arise in the clinical genomics sequencing segment, which will gain $3.92 billion of global annual sales by 2030. The top opportunities in the clinical genomics sequencing, biobank, database services market segmented by end-user will arise in the pharmaceutical and biotechnology companies segment, which will gain $4.17 billion of global annual sales by 2030. The clinical genomics sequencing, biobank, database services market size will gain the most in the USA at $1.97 billion.
Market-trend-based strategies for the clinical genomics sequencing, biobank, database services market include focus on integration of AI-designed genome editing with clinical-grade iPSC manufacturing, focus on growth of commercial genomic data platforms offering subscription-based and partnership-driven access models, focus on adoption of cloud-based secure genomic data access and analysis environments for multi-stakeholder collaboration, focus on rising demand for clinically interpretable and regulatory-grade genomic sequencing services, focus on integration of multi-omics data with clinical genomics and longitudinal health records, focus on collaborative integration of longitudinal clinical and genomic datasets to enable advanced insights across populations, focus on institutional investment in scalable biobank resources to support precision medicine, focus on advancement toward multi-modal, high-throughput spatial biology systems and focus on standardization and interoperability of clinical genomic databases across healthcare and research systems.
Player-adopted strategies in the clinical genomics sequencing, biobank, database services market include focus on strengthening business through strategic partnerships, focus on strategic acquisitions for future growth and focus on new investments for future growth.
To take advantage of the opportunities, the analyst recommends the clinical genomics sequencing, biobank, database services companies to focus on integrating AI-driven genome editing with scalable clinical data infrastructure, focus on secure cloud-based integration for genomic data access, focus on clinically validated sequencing and integrated data partnerships, focus on integrating multi-omics and clinical data, focus on expanding data integration and collaborative partnerships, focus on integrating spatial biology with genomics and data services, focus on commercial services for rapid growth, expand in emerging markets, continue to focus on developed markets, focus on expanding distribution channels and access points, focus on value-based and tiered pricing strategies, build credibility and awareness through targeted scientific engagement, prioritize direct engagement and account-based marketing and prioritize direct engagement and account-based marketing.
This product will be delivered within 3-5 business days.
The global clinical genomics sequencing, biobank, database services market reached a value of nearly $8.1 billion in 2025, having grown at a compound annual growth rate (CAGR) of 15.6% since 2020. The market is expected to grow from $8.1 billion in 2025 to $15.88 billion in 2030 at a rate of 14.4%. The market is then expected to grow at a CAGR of 13.7% from 2030 and reach $30.18 billion in 2035.
Growth in the historic period resulted from rising prevalence of diseases with genetic components, growth in clinical trials and research activities, expansion of biobanks and sample repositories and rising prevalence of rare diseases. Factors that negatively affected growth in the historic period were ethical and public trust concerns and data integration and interoperability issues.
Going forward, rising adoption of precision and personalized medicine, growing pharma demand for genomic data in drug discovery, rising prevalence of chronic diseases and expansion of pharmacogenomics testing will drive growth. Factors that could hinder the growth of the clinical genomics sequencing, biobank, database services market in the future include high sequencing and biobanking costs, data privacy and regulatory barriers and impact of trade war and tariff.
The clinical genomics sequencing, biobank, database services market is segmented by funding type into government-sponsored and commercial services. The commercial services market was the largest segment of the clinical genomics sequencing, biobank, database services market segmented by funding type, accounting for 57.7% or $4.65 billion of the total in 2025. Going forward, the commercial services segment is expected to be the fastest growing segment in the clinical genomics sequencing, biobank, database services market segmented by funding type, at a CAGR of 18.1% during 2025-2030.
The clinical genomics sequencing, biobank, database services market is segmented by disease area into oncology, rare genetic disorders, infectious diseases, reproductive health and other disease areas. The oncology market was the largest segment of the clinical genomics sequencing, biobank, database services market segmented by disease area, accounting for 40.3% or $3.26 billion of the total in 2025. Going forward, the rare genetic disorders segment is expected to be the fastest-growing segment in the clinical genomics sequencing, biobank, database services market segmented by disease area, at a CAGR of 15.3% during 2025-2030.
The clinical genomics sequencing, biobank, database services market is segmented by end-user into hospitals and clinics, diagnostic laboratories, research institutes and universities, pharmaceutical and biotechnology companies, contract research organizations (CROs) and other end users. The pharmaceutical and biotechnology companies market was the largest segment of the clinical genomics sequencing, biobank, database services market segmented by end-user, accounting for 45.3% or $3.67 billion of the total in 2025. Going forward, the pharmaceutical and biotechnology companies segment is expected to be the fastest-growing segment in the clinical genomics sequencing, biobank, database services market segmented by end-user, at a CAGR of 16.4% during 2025-2030.
The clinical genomics sequencing, biobank, database services market is segmented by service type into clinical genomics sequencing, biobank services and database and bioinformatics services. The clinical genomics sequencing market was the largest segment of the clinical genomics sequencing, biobank, database services market segmented by service type, accounting for 49.4% or $4.0 billion of the total in 2025. Going forward, the database and bioinformatics services segment is expected to be the fastest growing segment in the clinical genomics sequencing, biobank, database services market segmented by service type, at a CAGR of 15.5% during 2025-2030.
The global clinical genomics sequencing, biobank, database services market is fairly concentrated, with large players operating in the market. The top 10 competitors in the market made up 25.30% of the total market in 2024. Illumina Inc was the largest competitor with a 3.30% share of the market, followed by Thermo Fisher Scientific Inc with 2.99%, BGI Genomics Co. Ltd with 2.78%, Eurofins Scientific SE with 2.72%, Quest Diagnostics Inc with 2.55%, Hamilton Company with 2.53%, Invitae Corp with 2.39%, Tempus AI Inc with 2.34%, Novogene Corporation with 1.96% and 23andMe Holding Inc with 1.74%.
The top opportunities in the clinical genomics sequencing, biobank, database services market segmented by funding type will arise in the commercial services segment, which will gain $6.05 billion of global annual sales by 2030. The top opportunities in the clinical genomics sequencing, biobank, database services market segmented by disease area will arise in the oncology segment, which will gain $3.17 billion of global annual sales by 2030. The top opportunities in the clinical genomics sequencing, biobank, database services market segmented by service type will arise in the clinical genomics sequencing segment, which will gain $3.92 billion of global annual sales by 2030. The top opportunities in the clinical genomics sequencing, biobank, database services market segmented by end-user will arise in the pharmaceutical and biotechnology companies segment, which will gain $4.17 billion of global annual sales by 2030. The clinical genomics sequencing, biobank, database services market size will gain the most in the USA at $1.97 billion.
Market-trend-based strategies for the clinical genomics sequencing, biobank, database services market include focus on integration of AI-designed genome editing with clinical-grade iPSC manufacturing, focus on growth of commercial genomic data platforms offering subscription-based and partnership-driven access models, focus on adoption of cloud-based secure genomic data access and analysis environments for multi-stakeholder collaboration, focus on rising demand for clinically interpretable and regulatory-grade genomic sequencing services, focus on integration of multi-omics data with clinical genomics and longitudinal health records, focus on collaborative integration of longitudinal clinical and genomic datasets to enable advanced insights across populations, focus on institutional investment in scalable biobank resources to support precision medicine, focus on advancement toward multi-modal, high-throughput spatial biology systems and focus on standardization and interoperability of clinical genomic databases across healthcare and research systems.
Player-adopted strategies in the clinical genomics sequencing, biobank, database services market include focus on strengthening business through strategic partnerships, focus on strategic acquisitions for future growth and focus on new investments for future growth.
To take advantage of the opportunities, the analyst recommends the clinical genomics sequencing, biobank, database services companies to focus on integrating AI-driven genome editing with scalable clinical data infrastructure, focus on secure cloud-based integration for genomic data access, focus on clinically validated sequencing and integrated data partnerships, focus on integrating multi-omics and clinical data, focus on expanding data integration and collaborative partnerships, focus on integrating spatial biology with genomics and data services, focus on commercial services for rapid growth, expand in emerging markets, continue to focus on developed markets, focus on expanding distribution channels and access points, focus on value-based and tiered pricing strategies, build credibility and awareness through targeted scientific engagement, prioritize direct engagement and account-based marketing and prioritize direct engagement and account-based marketing.
This product will be delivered within 3-5 business days.
Table of Contents
1 Executive Summary
6 Market Characteristics
7 Major Market Trends
8 Global Clinical Genomics Sequencing, Biobank, Database Services Growth Analysis and Strategic Analysis Framework
9 Information on Value Propositions for Different Customers (End Users) and Specific Use Cases in Clinical Genomics Sequencing, Biobank, Database Services Market
10 Information on Maturity of Clinical Genomics Sequencing, Biobank, Database Services Market
11 Information on Opportunities and Challenges for Newer Players in the Clinical Genomics Sequencing, Biobank, Database Services Market
12 Explicitly Assess Successful and Unsuccessful Models, With Case-Based Insights
14 Global Clinical Genomics Sequencing, Biobank, Database Services Market Growth Rate Analysis
15 Global Clinical Genomics Sequencing, Biobank, Database Services Market Segmentation
16 Clinical Genomics Sequencing, Biobank, Database Services Market, Regional and Country Analysis
17 Asia-Pacific Market
18 Europe Market
19 USA Market
20 Rest of the World Market
21 Competitive Landscape and Company Profiles
22 Other Major and Innovative Companies
25 Key Mergers and Acquisitions
26 Recent Developments in Clinical Genomics Sequencing, Biobank, Database Services
27 Opportunities and Strategies
28 Clinical Genomics Sequencing, Biobank, Database Services Market, Conclusions and Recommendations
29 Appendix
Executive Summary
Clinical Genomics Sequencing, Biobank, Database Services Global Market Opportunities and Strategies to 2035 provides the strategists; marketers and senior management with the critical information they need to assess the global clinical genomics sequencing, biobank, database services market as it emerges from the COVID-19 shut down.Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 13 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description
Where is the largest and fastest-growing market for clinical genomics sequencing, biobank, database services? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The clinical genomics sequencing, biobank, database services market global report answers all these questions and many more.The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider clinical genomics sequencing, biobank, database services market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by funding type, by disease area, by service type and by end-user.
- Key Trends Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Growth Analysis and Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2020-2025) and forecast (2025-2030, 2035F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Regional and Country Analysis Historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison by region and country.
- Market Segmentation Contains the market values (2020-2025) (2025-2030, 2035F) and analysis for each by funding type, by disease area, by service type and by end-user in the market. Historic (2020-2025) and forecast (2025-2030) and (2030-2035) market values and growth and market share comparison by region market.
- Regional Market Size and Growth Regional market size (2025), historic (2020-2025) and forecast (2025-2030, 2035F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Europe, Rest of the World (ROW) within each region.
- Competitive Landscape Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major and Innovative Companies Details on the company profiles of other major and innovative companies in the market.
- Competitive Benchmarking Briefs on the financials comparison between major players in the market.
- Competitive Dashboard Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Recent Developments Information on recent developments in the market covered in the report.
- Market Opportunities and Strategies Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions and Recommendations This section includes recommendations for clinical genomics sequencing, biobank, database services providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
- Appendix This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report
1) By Funding Type: Government‑Sponsored; Commercial Services
2) By Disease Area: Oncology; Rare Genetic Disorders; Infectious Diseases; Reproductive Health; Other Disease Areas
3) By Service Type: Clinical Genomics Sequencing; Biobank Services; Database and Bioinformatics Services
4) By End-User: Hospitals and Clinics; Diagnostic Laboratories; Research Institutes and Universities; Pharmaceutical and Biotechnology Companies; Contract Research Organizations (CROs); Other End Users
Companies Mentioned: Illumina Inc.; Thermo Fisher Scientific Inc.; BGI Genomics Co. Ltd.; Eurofins Scientific SE ; Quest Diagnostics Inc.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; clinical genomics sequencing, biobank, database services indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
- Illumina Inc.
- Thermo Fisher Scientific Inc.
- BGI Genomics Co. Ltd.
- Eurofins Scientific SE
- Quest Diagnostics Inc.
- Hamilton Company
- Invitae Corp.
- Tempus AI Inc.
- Novogene Corporation
- 23andMe Holding Inc.
- MGI Tech Co., Ltd.
- MedGenome Labs Ltd.
- Strand Life Sciences Pvt. Ltd.
- Takara Bio Inc.
- Sysmex Corporation
- Healius Limited
- Eone-Diagnomics Genome Center (EDGC)
- Theragen Bio Co., Ltd.
- Berry Genomics Co., Ltd.
- PT Nalagenetics
- EDGC (Eone Diagnomics Genome Center)
- Theragen Bio
- GC Genome
- 3billion, Inc.
- DNAlink, Inc.
- Eurofins Scientific
- Oxford Nanopore Technologies plc
- F. Hoffmann-La Roche Ltd.
- QIAGEN N.V.
- AstraZeneca PLC
- BioNTech SE
- Genomics England
- Macrogen Europe B.V.
- deCODE genetics
- SeqOne Genomics
- Merck KGaA
- Dante Genomics
- Medicover Genetics
- Genomica
- Labcorp Holding Inc. (including Covance)
- GENEWIZ from Azenta
- Centogene GmbH
- Revvity Inc.
- Source BioScience
- ATLAS Biolabs
- SeqMatic
- Psomagen Inc.
- Charles River Laboratories
- Crown Bioscience
- Biomed International
- Syngene International Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 352 |
| Published | May 2026 |
| Forecast Period | 2025 - 2035 |
| Estimated Market Value ( USD | $ 8.1 Billion |
| Forecasted Market Value ( USD | $ 30.18 Billion |
| Compound Annual Growth Rate | 14.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 51 |
